表紙
市場調查報告書

血液疾病 (貧血等) 治療藥的全球市場:未來預測

Anemia And Other Blood Disorder Drugs Global Market Report 2020

出版商 The Business Research Company 商品編碼 916232
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
血液疾病 (貧血等) 治療藥的全球市場:未來預測 Anemia And Other Blood Disorder Drugs Global Market Report 2020
出版日期: 2019年11月01日內容資訊: 英文
簡介

本報告提供全球貧血等的面向血液疾病治療藥的市場結構、趨勢相關分析,市場的主要特徵、結構,及整體市場規模、成長率趨勢預測 (過去5年份、今後4年份,及長期的預測),跟各類型、各流通管道、各給藥途徑、貧血的各類型、各地區、主要國家詳細趨勢,主要的宏觀經濟指標的對比,主要企業的簡介,近幾年的市場主要趨勢等調查彙整。

第1章 摘要整理

第2章 市場特徵:血液疾病 (貧血等) 治療藥市場

第3章 血液疾病 (貧血等) 治療藥市場:市場規模與成長率

  • 市場規模的成果值 (以金額為準,過去5年份)
  • 市場規模的預測值 (以金額為準,今後4年份)
    • 推動市場要素
    • 阻礙市場要素

第4章 血液疾病 (貧血等) 治療藥市場:各領域分析

  • 各種類的市場規模:成果值、預測值
    • 缺鐵性貧血
    • 慢性腎性貧血
    • 鐮狀細胞貧血症
    • 再生不良性貧血
  • 各流通管道的市場規模:成果值、預測值
    • 醫院藥局
    • 線上藥局
    • 一般藥局
  • 給藥途徑 (RoA) 各的市場規模:成果值、預測值
    • 口服給藥
    • 注射
  • 貧血的各種類的市場規模:成果值、預測值
    • 小紅血球性貧血 (低MCV (平均紅血球容量))
    • 正紅血球性貧血 (正MCV)
    • 大紅血球性貧血 (高MCV)

第5章 血液疾病 (貧血等) 治療藥市場:各地區、各國分析

  • 各地區的市場規模:成果值、預測值
  • 各國市場規模:成果值、預測值

第6章 亞太地區的血液疾病 (貧血等) 治療藥市場

  • 市場概要
  • 市場規模:各類型
  • 市場規模:各流通管道

第7章 中國市場

第8章 印度市場

第9章 日本市場

第10章 澳洲市場

第11章 印尼市場

第12章 韓國市場

第13章 西歐的血液疾病 (貧血等) 治療藥市場

第14章 英國市場

第15章 德國市場

第16章 法國市場

第17章 東歐的血液疾病 (貧血等) 治療藥市場

第18章 俄羅斯市場

第19章 北美的血液疾病 (貧血等) 治療藥市場

第20章 美國市場

第21章 南美的血液疾病 (貧血等) 治療藥市場

第22章 巴西市場

第23章 中東的血液疾病 (貧血等) 治療藥市場

第24章 非洲的血液疾病 (貧血等) 治療藥市場

第25章 血液疾病 (貧血等) 治療藥市場:競爭環境和企業簡介

  • 競爭環境
  • 企業簡介
    • Amgen Inc.
      • 概要
      • 產品、服務
      • 策略
      • 財務成果
    • GlaxoSmithKline plc
    • Akebia therapeutics
    • Bayer AG
    • Pfizer, Inc.

第26章 血液疾病 (貧血等) 治療藥市場上主要企業合併、收購 (M&A)的動向

第27章 血液疾病 (貧血等) 治療藥市場:趨勢與策略

第28章 產品平台分析

第29章 血液疾病 (貧血等) 治療藥市場:未來展望與潛在力分析

第30章 附錄

目錄

Title:
Anemia And Other Blood Disorder Drugs Global Market Report 2020 - Including: 1) By Type: Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia 2) By Distribution Channel: Hospitals Pharmacy, Online Pharmacy, Pharmacy 3) By Route of Administration: Oral, Injectable 4) By Anemia Type: Microcytic (Low MCV), Normocytic (Normal MCV), Macrocytic (High MCV) Covering: Amgen Inc., GlaxoSmithKline plc, Akebia therapeutics, Bayer AG, Pfizer, Inc..

Anemia And Other Blood Disorder Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global anemia and other blood disorder drugs market.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the anemia and other blood disorder drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Anemia And Other Blood Disorder Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

  • Markets Covered: 1) By Type: Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia 2) By Distribution Channel: Hospitals Pharmacy, Online Pharmacy, Pharmacy 3) By Route of Administration: Oral, Injectable 4) By Anemia Type : Microcytic (Low MCV), Normocytic (Normal MCV), Macrocytic (High MCV)
  • Companies Mentioned: Amgen Inc., GlaxoSmithKline plc, Akebia therapeutics , Bayer AG , Pfizer, Inc.
  • Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
  • Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time Series: Five years historic and forecast.
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Anemia And Other Blood Disorder Drugs Market Characteristics

3. Anemia And Other Blood Disorder Drugs Market Size And Growth

  • 3.1. Global Anemia And Other Blood Disorder Drugs Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Anemia And Other Blood Disorder Drugs Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Anemia And Other Blood Disorder Drugs Market Segmentation

  • 4.1. Global Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Iron Deficiency Anemia
  • Chronic Kidney Disease Anemia
  • Sickle Cell Anemia
  • Aplastic Anemia
  • 4.2. Global Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Hospitals Pharmacy
  • Online Pharmacy
  • Pharmacy
  • 4.3. Global Anemia And Other Blood Disorder Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Oral
  • Injectable
  • 4.4. Global Anemia And Other Blood Disorder Drugs Market, Segmentation By Anemia Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Microcytic (Low MCV)
  • Normocytic (Normal MCV)
  • Macrocytic (High MCV)

5. Anemia And Other Blood Disorder Drugs Market Regional And Country Analysis

  • 5.1. Global Anemia And Other Blood Disorder Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 5.2. Global Anemia And Other Blood Disorder Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Anemia And Other Blood Disorder Drugs Market

  • 6.1. Asia-Pacific Anemia And Other Blood Disorder Drugs Market Overview
  • 6.2. Asia-Pacific Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Anemia And Other Blood Disorder Drugs Market

  • 7.1. China Anemia And Other Blood Disorder Drugs Market Overview
  • 7.2. China Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
  • 7.3. China Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Anemia And Other Blood Disorder Drugs Market

  • 8.1. India Anemia And Other Blood Disorder Drugs Market Overview
  • 8.2. India Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 8.3. India Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Anemia And Other Blood Disorder Drugs Market

  • 9.1. Japan Anemia And Other Blood Disorder Drugs Market Overview
  • 9.2. Japan Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 9.3. Japan Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Anemia And Other Blood Disorder Drugs Market

  • 10.1. Australia Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 10.2. Australia Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Anemia And Other Blood Disorder Drugs Market

  • 11.1. Indonesia Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Anemia And Other Blood Disorder Drugs Market

  • 12.1. South Korea Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Anemia And Other Blood Disorder Drugs Market

  • 13.1. Western Europe Anemia And Other Blood Disorder Drugs Market Overview
  • 13.2. Western Europe Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Anemia And Other Blood Disorder Drugs Market

  • 14.1. UK Anemia And Other Blood Disorder Drugs Market Overview
  • 14.2. UK Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 14.3. UK Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Anemia And Other Blood Disorder Drugs Market

  • 15.1. Germany Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 15.2. Germany Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Anemia And Other Blood Disorder Drugs Market

  • 16.4. France Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 16.5. France Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Anemia And Other Blood Disorder Drugs Market

  • 17.1. Eastern Europe Anemia And Other Blood Disorder Drugs Market Overview
  • 17.2. Eastern Europe Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Anemia And Other Blood Disorder Drugs Market

  • 18.1. Russia Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 18.2. Russia Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Anemia And Other Blood Disorder Drugs Market

  • 19.1. North America Anemia And Other Blood Disorder Drugs Market Overview
  • 19.2. North America Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 19.3. North America Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Anemia And Other Blood Disorder Drugs Market

  • 20.1. USA Anemia And Other Blood Disorder Drugs Market Overview
  • 20.2. USA Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 20.3. USA Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Anemia And Other Blood Disorder Drugs Market

  • 21.1. South America Anemia And Other Blood Disorder Drugs Market Overview
  • 21.2. South America Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 21.3. South America Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Anemia And Other Blood Disorder Drugs Market

  • 22.1. Brazil Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Anemia And Other Blood Disorder Drugs Market

  • 23.1. Middle East Anemia And Other Blood Disorder Drugs Market Overview
  • 23.2. Middle East Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Anemia And Other Blood Disorder Drugs Market

  • 24.1. Africa Anemia And Other Blood Disorder Drugs Market Overview
  • 24.2. Africa Anemia And Other Blood Disorder Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 24.3. Africa Anemia And Other Blood Disorder Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Anemia And Other Blood Disorder Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Anemia And Other Blood Disorder Drugs Market Competitive Landscape
  • 25.2. Anemia And Other Blood Disorder Drugs Market Company Profiles
    • 25.2.1. Amgen Inc.
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. GlaxoSmithKline plc
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Akebia therapeutics
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Bayer AG
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Pfizer, Inc.
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Anemia And Other Blood Disorder Drugs Market

27. Anemia And Other Blood Disorder Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Anemia And Other Blood Disorder Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
Back to Top